Cytomed Therapeutics reported earnings per share of S$0.09 in the first half, compared to a loss of S$0.22 in the same period last year.
Click to view the full story on thefly.com for the most up-to-date financial news. The Fly is recognized for its market insight and offers a real-time news feed to keep readers informed.